A Phase I Study of C-CAR088, a Novel Humanized Anti-BCMA CAR T Cell Therapy in Relapsed/Refractory Multiple Myelomaa

Xiaoyan Qu, Gang An, Weiwei Sui, Tingyu Wang, Xian Zhang, Junfang Yang, Yan Zhang, Lu Zhang, Dan Zhu, Jia‐Qi Huang, Shigui Zhu, Xin Yao, Jing Li, Chengxiao Zheng, Kevin Zhu, Yutiang Wei, Xiaoteng Lv, Liping Lan, Yihong Yao, Daobin Zhou, Peihua Lu, Lugui Qiu, Jianyong LiSSRN 2022 · DOI

BibTeX
@misc{qu2022phase,
  author = {Xiaoyan Qu and Gang An and Weiwei Sui and Tingyu Wang and Xian Zhang and Junfang Yang and Yan Zhang and Lu Zhang and Dan Zhu and Jia‐Qi Huang and Shigui Zhu and Xin Yao and Jing Li and Chengxiao Zheng and Kevin Zhu and Yutiang Wei and Xiaoteng Lv and Liping Lan and Yihong Yao and Daobin Zhou and Peihua Lu and Lugui Qiu and Jianyong Li},
  title = {{A Phase I Study of C-CAR088, a Novel Humanized Anti-BCMA CAR T Cell Therapy in Relapsed/Refractory Multiple Myelomaa}},
  year = {2022},
  doi = {10.2139/ssrn.4059229},
  howpublished = {SSRN},
}

Loading related content...

Figure